Skip to main content
An official website of the United States government

Past Events

  • Tech Webinar: Pigment Epithelium-Derived Factor Peptides for Treating Retinal Degeneration

    This webinar was originally scheduled for January 31, and rescheduled for May 22; it will now be rescheduled for fall 2024.
    Attendees will learn about a potential, novel treatment for Retinitis Pigmentosa (RP). Over 100,000 in the U.S. and 1.5 million people worldwide suffer from RP, which leads to progressive photoreceptor cell degeneration and ultimately vision loss. A new therapeutic technology from the National Eye Institute has the potential to be a treatment option for RP patients and may also protect retinal cells from damage associated with glaucoma and age-related macular degeneration (AMD). Attend the webinar to assess the technology for partnership and licensing opportunities.

    May 22, 2024 | 11:00 AM – 12:00 PM
  • PIM-Targeted PROTACs

    Webinar attendees will learn about a new family of Proteolysis Targeting Chimeras (PROTACS) that selectively target Proviral Integration for the Moloney murine leukemia virus (PIM) kinases. PIM kinases play a role in cancer development and mediating resistance to radio and chemotherapy, and are overexpressed in multiple cancers. Several small molecule PIM kinase inhibitors have had minimal effect in suppressing cancer phenotypes due to the PIM kinase inhibitors promoting intrinsic resistance. By contrast, these PIM-targeted PROTACs suppress PIM kinase activity and avoid intrinsic resistance.

    April 24, 2024 | 11:00 AM – 12:00 PM
  • New Covid Vaccine to Prevent Infection and Transmission

    In this free webinar hosted by TTC, attendees will learn about a new adjuvanted subunit mucosal Covid-19 vaccine that incorporates a unique nanoparticle formulation. In vivo study results demonstrated that it can protect against respiratory SARS-CoV-2 exposure and may enhance the protective effect of systemic vaccines. This makes it a good candidate for a SARS-CoV-2 vaccine. Attend the webinar to hear from the NCI inventor and learn more about the technology which is available for collaboration and licensing.

    March 13, 2024 | 11:00 AM – 12:00 PM
  • Technology Opportunity Webinar: Nestorone®/Testosterone Male Contraceptive Gel

    In this free, NIH webinar hosted by TTC, attendees will learn about a first-of-its-kind male contraceptive hormonal gel, Nestorone/Testosterone (NES/T), co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical daily self-applied transdermal gel is designed to provide full sperm suppression within 8-12 weeks and be reversible after 12-16 weeks of ending application. This presentation will showcase NES/T gel as an innovative user-controlled option for male contraception.

    December 12, 2023 | 11:00 AM – 12:00 PM
  • Technology Opportunity Webinar: Automated Benchtop Acoustophoresis Device

    Learn about a technology opportunity webinar presented by the inventor of a new medical device, Dr. Stephen Adler of the NCI. The NCI is seeking partners to further develop the technology entitled "Automated Benchtop Acoustophoresis Device to Radio-Label & Isolate Cells for Immunotherapy Treatment"

    November 15, 2023 | 11:00 AM – 12:00 PM
  • Webinar Anti-EGFR Antibodies for the Treatment of Human Cancers

    Attend a free webinar to assess co-developing an NCI technology, "Anti-EGFR Antibodies for the Treatment of Human Cancers." The presentation will follow a logical sequence of how anti-EGFR antibodies are generated and modified to make them cytotoxic for tumor cells.

    October 25, 2023 | 11:00 AM – 12:00 PM
  • 2023 Technology Showcase

    Register for the 2023 Technology Showcase on September 6th.

    September 6, 2023 | 10:00 AM – 4:30 PM
    Frederick, MD
  • Tech Opportunity Webinar to feature a New Therapeutic Target in Pancreatic Cancer

    The NCI Technology Transfer Center will host a technology opportunity webinar on Wednesday, August 23 from 11:00 a.m. - 12:00 p.m. ET that will highlight a new therapeutic target in pancreatic cancer. Dr, Mitchell Ho, deputy chief, NCI Laboratory of Molecular Biology, is the featured presenter.

    August 23, 2023 | 11:00 AM – 12:00 PM
  • Webinar: Harnessing Anti-Cytomegalovirus Immunity for Local Immunotherapy Against Solid Tumors

    Deputy Chief of the NCI CCR Laboratory of Cellular Oncology, John Schiller, Ph.D. presents a new immunotherapy method targeting solid tumors.

    December 15, 2022 | 10:00 AM – 11:00 AM
  • Opportunity Webinar Harnessing Anti-Cytomegalovirus Immunity for Local Immunotherapy against Solid Tumors

    Learn about a TTC-Hosted Technology Opportunity Webinar presented by NCIs’ Dr. John Schiller entitled “Harnessing Anti-Cytomegalovirus Immunity for Local Immunotherapy against Solid Tumors.”

    December 14, 2022 | 11:00 AM – 12:00 PM